Effect of Ethanol Leaf Extract of Newboulda Laevis on Blood Glucose Levels of Diabetic Rats by Owolabi, OJ et al.
Owolabi et al  
Trop J Pharm Res, June 2011;10 (3): 249 
Tropical Journal of Pharmaceutical Research June 2011; 10 (3): 249-254 
© Pharmacotherapy Group,  
Faculty of Pharmacy, University of Benin,  
Benin City, 300001 Nigeria.  
All rights reserved. 
 






Effect of Ethanol Leaf Extract of Newboulda Laevis on 
Blood Glucose Levels of Diabetic Rats 
 
Omonkhelin J Owolabi1*, Fabian C Amaechina1 and Mercy Okoro2  
1
Department of Pharmacology and Toxicology, 
2
Department of Science Laboratory Technology, University of Benin, 





Purpose: To investigate anti-diabetic effect of the ethanol leaf extract of Newbouldia laevis (P. Beauv) 
in alloxan-induced diabetic rats. 
Methods: Alloxan (150 mg/kg) was administered to wistar albino rats via the intraperitoneal route. The 
diabetic rats were then placed in 5 groups, following stabilization of hyperglycemia. The first group was 
untreated, the next three groups received, each day, 100, 200 and 400 mg/kg body weight of the 
ethanol extract Newbouldia laevis and the fifth group received a reference standard, glibenclamide (5 
mg/kg). Treatment was via the oral route for 14 days and fasting blood sugar level was monitored over 
this period. Acute toxicity (oral and intraperitoneal) studies on the extract was carried out, as well as 
phytochemical screening of the extract. 
Results: All doses of the extract (100, 200, and 400 mg/kg) significantly (p < 0.05, p < 0.0001, p <0.05, 






 day. Glibenclamide (5 
mg /kg) also significantly lowered fasting blood glucose (p < 0.0001). The results on acute toxicity 
revealed that for the oral and intraperitoneal route, mortality was  at 8 and 1 g/kg, respectively while 
LD50 was 6 g/kg, indicating the high safety status of the plant. Phytochemical screening revealed the 
presence of saponins, tannins, alkaloids and flavonoids.    
Conclusion: This study supports the use of Newboulda laevis in traditional medicine as well as 
highlights the need to further explore the potentials of the plant extract as a antihyperglycemic agent. 
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INTRODUCTION 
 
The reasons to study medicinal plants include 
the widespread use of plants in folk 
medicines, good safety profile of plants and 
their ready availability [1]. Plant resources are 
a veritable source of pharmaceuticals and 
therapeutics, but they have not been 
adequately documented [2].  
 
Traditional medicinal practice has existed in 
Africa and other cultures for centuries since 
man came into being but recently it has been 
neglected due to undue pressure from 
orthodox medical practitioners and the 
unscientific background of its method of 
operation [3]. There is renewed worldwide 
interest in traditional medicine which is 
derived from the realization that orthodox 
medicine is not widespread in poor countries 
whereas healthcare has virtually been 
sustained by these cultural alternatives [3]. 
 
Diabetes is a chronic metabolic disorder 
which is characterized by hyperglycaemia as 
a result of the diminished production of 
insulin or mounting resistance to its action [4]. 
Chronic hyperglycaemia during diabetes 
causes glycation of body proteins thereby 
affecting the eyes, kidney, nerves and 
arteries [4].  
 
The plant, Newbouldia laevis (P.Beauv), is 
called Aduruku in Hausa, Ogirisi in Ibo and 
Akoko in Yoruba languages of Nigeria [5]. It 
is a medium size angiosperm which belongs 
to the Bignoniaceae family. It grows to a 
height of about 7 - 8m, but more usually as a 
shrub of 3m. It has many stem forming 
clumps of gnarled branches [6,7]. The plant, 
native to tropical Africa, is used traditionally 
for the treatment of diabetes, diarrhoea, 
dysentery and in pregnancy [6]. 
 
This study was designed to test the 
hypoglycaemic effect of the ethanol extract of 
the leaves of Newbouldia laevis on alloxan 
induced diabetic rats, because of its local use 
amongst the binins, ibos and yourubas 
speaking areas in Nigeria in the  treatment of 
diabetes mellitus [6].  





The leaves of Newbouldia laevis were 
collected from Ugbowo area of Benin City, 
Nigeria, in the month of July 2009. The plant 
was identified by Mr S Nweke of the 
Department of Pharmacogonosy, Faculty of 
Pharmacy, University of Benin, Benin City. 
Botanical authentication of the plant was 
confirmed at the Forestry Research Institute 
of Nigeria (FRIN) Ibadan, Nigeria where a 
voucher specimen (No FHI 107753) was 
deposited for future reference.   
 
Extract preparation  
 
The leaves of Newbouldia laevis were air-
dried for several days and then pulverized 
into fine powder. About 500 g of the 
powdered leaves was extracted exhaustively 
via marceration for 72 h with 2.8 L of 70 % 
absolute ethanol. Filtration was carried out 
using a funnel and filter paper. The extract 
was concentrated in an evaporating dish over 
a hot water bath. The yield was 38.28 %.   
 
Drugs and chemicals  
 
Alloxan and glibenclamide (Sigma-Aldrich, 
UK), and 95 % ethanol (Sosol Inc, South 
Africa) were used. All other chemicals and 
drugs used were of analytical grade. 
 
Experimental animals  
 
Adult albino rats and mice of both sexes and 
weighing 135 - 255 g and 20 - 30 g, 
respectively, were used for the study. The 
animals were obtained from the animal house 
of the Department of Pharmacology and 
Toxicology, University of Benin, Benin City, 
Nigeria. They were kept in standard cages in 
a well-ventilated room, fed with standard 
growers mash (Bendel Feeds and Flour Mills 
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Ltd, Ewu, Edo State, Nigeria) and allowed 
water ad libitum.  
 
Ethical approval for the study was obtained 
from the Ethical Committee on the Use of 
Animals for Experiments, Faculty of 
Pharmacy, University of Benin. The animals 
were handled according to the standard 





Freshly prepared extracts of Newbouldia 
laevis were subjected to preliminary 
phytochemical screening for various 
constituents. The methods of analysis 
employed was as previously described [9,10]. 
 
Acute toxicity studies  
 
The acute toxicity of the plant extract was 
evaluated using the method described by 
Lorke [11]. The mice were divided into 5 
groups of 5 mice each. The first group was 
treated with 2 ml/kg of normal saline. This 
served as the control. The second, third, 
fourth and fifth groups were treated with the 
ethanol extract of the plant at doses of 1,000, 
2,000, 4,000 and 8,000 mg/kg, respectively. 
All administrations were carried out orally via 
an oro-gastric syringe. The mice were then 
observed for 24 h for signs of toxicity and 
mortality. Intraperitoneal acute toxicity test 
was similarly carried out using the same 
series of doses but on separate groups of 
mice. [11]. 
 
Induction of diabetes mellitus  
 
Twenty five albino rats of both sexes 
weighing 135 - 255g were used. The rats 
were fasted overnight prior to injection with 
alloxan dissolved in normal saline at a dose 
of 150 mg/kg intraperitoneally for 5 days. 
Rats with blood glucose levels greater than 
200 mg/dl were considered diabetic and used 
for this investigation [12]. 
 
Antidiabetic treatment  
 
The alloxan-diabetic albino rats which were 
fasted were placed in 5 groups (groups 2 - 6) 
of 5 rats each and treated as follows: group 1 
(normal rats) received normal saline orally for 
14 days; group 2 were untreated diabetic 
rats; groups 3, 4 and 5, which were all 
diabetic, received orally 100, 200, 400 mg/kg 
of the extract, respectively, for 14 days. The 
6
th
 group (diabetic) received 5 mg/kg of 
glibenclamide orally for 14 days. These 
doses were selected after an initial 
preliminary work done using various doses 
on diabetic rats. 
 
Measurement of blood glucose levels  
 
All blood samples were collected by cutting 
the tail-tip of the overnight fasted rats. Blood 
samples for fasting blood glucose 
determination were collected at intervals of 2, 
4, 8, 24 h and on the 14
th
 day following 
treatment. Measurement of the blood glucose 
level (mg/dl) was carried out using Acco-
Chek Active blood pressure monitor and 




All data were expressed as mean ± SEM and 
where applicable, the data were analysed 
statistically by Student’s t-test using Graph 
Pad Instat software, version 2.05a. P < 0.05 







The results on the phytochemical analysis 
revealed the presence of alkaloids, saponins, 




The sign of toxicity were noticed from 30 min 
to 4 h following the administration of the 
extract for both oral and intraperitoneal 
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routes. There was prostration and increased 
sensitivity to sound after about 1 h. There 
was also increased feed intake after about 30 
min of extract administration, followed by 
itching and decreased movement after about 
3 h of extract administration. There was 
weight loss after 14 days, and death for the 1 
and 8 g/kg groups after 24 h of extract 
administration in the oral and intraperitoneal 
routes, respectively. The median lethal dose 
(LD50) was 6g/kg for the intraperitoneal route, 
and indeterminate for the oral route. These 




The anti-diabetic effect of the extract is  
shown in Fig 2. The 100 mg/kg dose of the 






 h and 14
th
 day of 
extract administration significantly (p < 0.05) 
reduced fasting blood glucose level from 226  
to 174.3, 181.5, 156.3 and 150 mg/dl, 
respectively.  
 
A similar effect was seen with the 200 mg/kg 
in which there was also significant reduction 
of fasting blood glucose levels from 294.5 to 
244 (p < 0.05), 144.8 (p < 0.0001), 110.0 (p < 









 day, respectively. The 
400 mg/kg dose showed the highest 
hypoglycaemic effect with significant (p < 
0.05, p < 0.0001) reductions in blood glucose 
level from 266.3 to 161.0, 158.5, 131.5 and 






 h, and 14
th
 
day. A significant blood sugar level reduction 
(p < 0.0001) was seen with glibenclamide 
over the same treatment period. 
 
Table 1: Oral acute toxicity data in mice for 
ethanol leaf extract of Newboulda laevis (n = 6) 
 





Extract (1 g/kg) 3.000 0 
Extract (2 g/kg) 3.301 0 
Extract (4 g/kg) 3.602 0 
Extract (8 g/kg) 3.903 40 
 
 
Fig 1: Acute toxicity studies (intraperitoneal) of 
ethanol leaf extract of Newboulda laevis in mice (n 




Fig 2:  Anti-diabetic effect of ethanol leaf extract of 
Newboulda laevis in rats (n = 6, error bars = SEM). 
Key: NS = normal saline; D+NS = diabetic given 
normal saline; D+NL(100) = diabetic group given 
100 mg/kg extract; D+NL(200) = diabetic given 
200 mg/kg extract; D+NL(400) = diabetic given 
400 mg/kg extract; D+GLI(5) = diabetic given 5 
mg/kg glibenclamide; 
a
p < 0.0001 significantly 
different from control; 
b
p < 0.05 and 
c
p < 0.0001 
significantly different from untreated diabetic rats 




Oral acute toxicity studies showed that the 
extract produced no mortality except at the 
dose of 8g/kg. This indicates that the extract 
has a wide margin of safety and LD50 could 
not be ascertained since no mortality was 
recorded at lower doses. Intrapentoneal (ip) 
administration of the extract caused mortality 
at 2 g/kg dose, with an LD50 of 6 g/kg which 
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confirms the safety of the plant. Induction of 
diabetes using alloxan has been described as 
a useful experimental model for studying the 
effect of hypoglycemic agents [14]. Alloxan 
and the product of its reduction, dialuric acid, 
establish a redox cycle with the formation of 
superoxide radicals. These radicals undergo 
dismutation to hydrogen peroxide with a 
simultaneous massive increase in cytosolic 
calcium concentration, resulting in the 
destruction of pancreatic β-cells and diabetes 
[14].  
 
The untreated diabetic rats had a significantly 
higher (p < 0.0001) fasting blood glucose 
level than normal rats that received normal 
saline. This confirms induction of diabetes by 
alloxan. The results show a dose-dependent 
lowering of fasting blood glucose level in 
diabetic rats treated with different doses of 
the extract. This dose-dependent effect 
compares well with glibenclamide, the 
reference drug used, especially at the 400 
mg/kg body weight dose, at which dose the 
extract produced a greater and more 
significant reduction of blood glucose level 
than 5 mg/kg glibenclamide on the 14th day. 
Glibenclamide is a standard drug that is 
routinely used in the treatment of diabetes 
[15]. 
 
The extract’s ability to significantly reduce 
hyperglycemia induced by alloxan may 
indicate a similar mechanism with 
glibenclamide which, being a sulphonylurea 
stimulates the release of insulin [16]. Alloxan 
destroys pancreatic β-cells and thus reduces 
or completely inhibit insulin secretion 
resulting in hyperglycemia [14]. Hence the 
release of insulin by glibenclamide produces 
a lowering of hyperglycemia. The extract also 
produced a similar reduction in blood sugar 
level and it is probable that it also enhanced 
insulin secretion but this needs to be 
investigated in future studies. However, the 
presence of flavonoids in the extract may 
account for the observed hypoglyceamic 
effect since they have been found to 
stimulate the secretion of insulin [17]. 
Glibenclamide (an oral hpoglycemic agent) is 
known to act by enhancing exogenous insulin 
contribution which thus corrects deficiency in 




The ethanol leaf extract of Newbouldia laevis 
demostrated antidiabetic activity in rats and 
acute toxicity studies also show it to be 
relatively safe. The findings from this work 
supports its use in traditional medicine. 
However, further studies are required to 
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